Skip to content

RA PHARMACEUTICALS, INC.: filings

Every RA PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 14 filings, each linked to its SEC index.

Filing record ends 2020-02-27

The latest filing in this captured record is a 10-K filed 2020-02-27. No later filing is in the SEC companyfacts record captured on 2026-09-22. RA PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2020-02-27fiscal FY 201941960001047469-20-001072
10-Q2019-11-07fiscal Q3 201936960001104659-19-060787
10-Q2019-08-07fiscal Q2 201935900001104659-19-044402
10-Q2019-05-09fiscal Q1 201935720001104659-19-027979
10-K2019-03-07fiscal FY 201838940001047469-19-000968
10-Q2018-11-07fiscal Q3 201833820001104659-18-066658
10-Q2018-08-08fiscal Q2 201833820001104659-18-050313
10-Q2018-05-09fiscal Q1 201833680001104659-18-031715
10-K2018-03-14fiscal FY 2017391190001047469-18-001637
10-Q2017-11-09fiscal Q3 201732770001104659-17-067376
10-Q2017-08-09fiscal Q2 201732780001104659-17-050701
10-Q2017-05-11fiscal Q1 201729590001104659-17-031903
10-K2017-03-06fiscal FY 2016351150001047469-17-001292
10-Q2016-11-29fiscal Q3 201633860001104659-16-159588

Inspect the source

Entity
RA PHARMACEUTICALS, INC. / CIK 0001481512
Captured
SEC response SHA-256
2709c428c21575ecd5ceb499c1e137fef37024f44d763b093c9267a5bd141d2b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001481512.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))